Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/5/2026

Management of Postpartum Hemorrhage

Definition and Timing

  • Primary postpartum hemorrhage (PPH) occurs within the first 24 hours after delivery, while secondary PPH occurs from 24 hours to 6 weeks postpartum, as defined by the American College of Radiology 1, 2

First-Line Management

  • The American College of Obstetricians and Gynecologists recommends oxytocin 5-10 IU IV or IM with uterine massage and bimanual compression as first-line management for PPH 3, 4
  • Tranexamic acid 1 g IV over 10 minutes is recommended if within 3 hours of birth, but is contraindicated beyond 3 hours as potentially harmful 3, 4, 5

Second-Line Pharmacotherapy

  • Methylergonovine 0.2 mg IM is an alternative second-line agent, but is contraindicated in hypertensive patients, according to the American College of Obstetricians and Gynecologists 4, 5

Mechanical Interventions

  • Intrauterine balloon tamponade has a success rate of 79.4-88.2% for uterine atony, as reported by the American College of Obstetricians and Gynecologists 3, 5
  • Pelvic pressure packing is recommended for acute uncontrolled hemorrhage, according to the American College of Surgeons 4, 5

Definitive Interventions

  • Uterine artery embolization is particularly useful when no single bleeding source is identified, as recommended by the Society of Interventional Radiology 4, 5
  • Uterine compression sutures (B-Lynch or similar) are recommended as a definitive intervention, according to the American College of Obstetricians and Gynecologists 5

Critical Timing Considerations

  • Tranexamic acid loses effectiveness by 10% for every 15 minutes of delay and should not be given beyond 3 hours postpartum, as recommended by the American College of Obstetricians and Gynecologists 3, 4, 5
  • At exactly 24 hours postpartum, tranexamic acid is contraindicated if not already administered, according to the American College of Obstetricians and Gynecologists 3

Common Pitfalls to Avoid

  • Delaying carboprost administration while waiting for laboratory results in active hemorrhage is not recommended, according to the American College of Obstetricians and Gynecologists 4
  • Maintaining normothermia is crucial, as clotting factors function poorly at lower temperatures, as recommended by the American College of Surgeons 4, 5
  • Initiating massive transfusion protocol if blood loss exceeds 1,500 mL is recommended, according to the American College of Surgeons 4, 5
  • Continuing hemodynamic monitoring for at least 24 hours after delivery is recommended due to significant fluid shifts, as suggested by the American College of Obstetricians and Gynecologists 3, 4, 5
  • Re-dosing prophylactic antibiotics if blood loss exceeds 1,500 mL is recommended, according to the American College of Obstetricians and Gynecologists 5

Rectal Misoprostol Administration at 24 Hours Postpartum

Introduction to Rectal Misoprostol

  • The American College of Obstetricians and Gynecologists recommends that rectal misoprostol should not be administered as a preventive measure at 24 hours postpartum, but may be considered as a treatment option for active postpartum hemorrhage if first-line therapies have failed 6

Critical Timing Considerations

  • Tranexamic acid administration is time-sensitive and should be given within 3 hours postpartum, as its effectiveness decreases by approximately 10% for every 15 minutes of delay after birth, and it is contraindicated beyond 3 hours postpartum 6

Treatment of Active Hemorrhage

  • Rectal misoprostol 800-1000 mcg may be used as a second-line treatment for active hemorrhage at 24 hours postpartum if the patient has failed to respond to oxytocin, with a reported hemorrhage control rate of 63% within 10 minutes 6
  • The World Health Organization recommends that rectal misoprostol 1000 mcg can achieve sustained uterine contraction within 3 minutes in patients with hemorrhage unresponsive to oxytocin and ergometrine 6

Dosing for Treatment

  • The evidence-based dose for treatment of active hemorrhage is 800 mcg sublingually, although 1000 mcg rectally has been used effectively in clinical studies 6

Proper Management Algorithm at 24 Hours Postpartum

  • The Royal College of Obstetricians and Gynaecologists recommends a management algorithm that includes first-line oxytocin 5-10 IU IV or IM with uterine massage and bimanual compression, followed by second-line pharmacotherapy options such as rectal misoprostol 800-1000 mcg if active hemorrhage is present 6

Tranexamic Acid in the Management of Postpartum Hemorrhage

Indications and Timing

  • Administer tranexamic acid 1 g IV as soon as postpartum hemorrhage is diagnosed, but only within 3 hours of birth; efficacy declines by ~10 % for every 15‑minute delay and there is no benefit after 3 hours. 7, 8
  • If bleeding continues after 30 minutes or recurs within 24 hours of the first dose, a second 1 g IV dose may be given. 7, 8
  • Tranexamic acid should be given in all cases of postpartum hemorrhage, regardless of whether the cause is genital‑tract trauma or uterine atony. 7, 8
  • This recommendation is broader than earlier guidance, which limited tranexamic acid use to situations where oxytocin and other treatments had already failed. 8

Contraindications

  • Avoid tranexamic acid in women with a known thromboembolic event during pregnancy. 7

REFERENCES

1

acr appropriateness criteria® postpartum hemorrhage. [LINK]

Journal of the American College of Radiology, 2020

2

acr appropriateness criteria® postpartum hemorrhage. [LINK]

Journal of the American College of Radiology, 2020

3

Management of Postpartum Hemorrhage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Postpartum Hemorrhage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Management of Postpartum Hemorrhage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025